These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 327405)

  • 1. [Estrogen and progesterone receptors in non carcinomatous breast diseases (author's transl)].
    May-Levin F; Contesso G; Guerinot F; Delarue JC; Bohuon C
    Pathol Biol (Paris); 1977 Apr; 25(4):233-9. PubMed ID: 327405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Content of 17 beta éstradiol, progesterone and glucocorticoid receptors in patients with benign breast diseases].
    Bassalyk LS; Kuz'mina ZV; Murav'eva NI; Smirnova KD; Vishniakova VV
    Vopr Onkol; 1982; 28(7):3-6. PubMed ID: 7101825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Steroid hormone receptors in the normal breast and in benign mastopathies].
    Kouyoumdjian JC; Feuilhade F; Pinaudeau Y; Rymer JC
    Bull Cancer; 1986; 73(2):120-3. PubMed ID: 3730631
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunohistochemical analysis of estrogen and progesterone receptors in benign breast diseases.
    Tóth J; De Sombre ER; Greene GL
    Zentralbl Pathol; 1991; 137(3):227-32. PubMed ID: 1931896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Steroid hormone receptors in benign breast diseases].
    Fournier S; Prud'homme JF; Martin PM; Kuttenn F
    Pathol Biol (Paris); 1983 Nov; 31(9):767-73. PubMed ID: 6361674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
    Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
    Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relationship of estrogen and progesterone receptors to the menstrual cycle and menopausal status at the time of breast surgery].
    Karbowski B; Jackisch C; Deppe B; Schneider HP
    Zentralbl Gynakol; 1999; 121(8):367-74. PubMed ID: 10486879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas.
    Wei B; Wang J; Bourne P; Yang Q; Hicks D; Bu H; Tang P
    Hum Pathol; 2008 Dec; 39(12):1809-15. PubMed ID: 18715613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Demonstration of estradiol and progesterone receptors in histological preparations].
    Fetissof F; Lansac J; Arbeille-Brassart B
    Ann Anat Pathol (Paris); 1980; 25(3):201-16. PubMed ID: 7015929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metaplastic breast carcinoma: pathology and clinical outcome.
    Bellino R; Arisio R; D'Addato F; Attini R; Durando A; Danese S; Bertone E; Grio R; Massobrio M
    Anticancer Res; 2003; 23(1B):669-73. PubMed ID: 12680165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of steroid hormone receptors in patients with mastopathies and fibroadenomas].
    Meissner J; Kasch R; Splitt G; Gerber B; Rhode E
    Zentralbl Gynakol; 1989; 111(23):1562-6. PubMed ID: 2624008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Estrogen and progresterone receptors in male breast diseases].
    Contesso G; Delarue JC; Guerinot F; May-Levin F; Bohuon C
    Nouv Presse Med; 1977 May; 6(22):1951-3. PubMed ID: 887385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoplasmic and nuclear estrogen and progesterone receptors in male breast cancer.
    Pegoraro RJ; Nirmul D; Joubert SM
    Cancer Res; 1982 Nov; 42(11):4812-4. PubMed ID: 7127316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
    Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
    Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cytoplasmic steroid hormone receptors in primary breast tumors].
    Bassalyk LS; Murav'eva NI; Smirnova KD; Kuz'mina ZV; Vishniakova VV
    Vopr Onkol; 1982; 28(4):6-10. PubMed ID: 7090272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of estrogen, progesterone, and epidermal growth factor receptors in normal, benign, and malignant human breast tissues using dual staining immunohistochemistry.
    van Agthoven T; Timmermans M; Foekens JA; Dorssers LC; Henzen-Logmans SC
    Am J Pathol; 1994 Jun; 144(6):1238-46. PubMed ID: 7515559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental and clinical aspects of hormone therapy in breast cancer (author's transl)].
    Maass H; Jonat W
    Arch Geschwulstforsch; 1981; 51(7):623-9. PubMed ID: 7337544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatment.
    Colleoni M; Viale G; Zahrieh D; Pruneri G; Gentilini O; Veronesi P; Gelber RD; Curigliano G; Torrisi R; Luini A; Intra M; Galimberti V; Renne G; Nolè F; Peruzzotti G; Goldhirsch A
    Clin Cancer Res; 2004 Oct; 10(19):6622-8. PubMed ID: 15475452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical and methodological considerations in the quantification of estrogen and progesterone receptors using monoclonal antibodies in breast cancer].
    Navarro MA; Huguet J; Valero J; Samaniego JM; Rosel P; Sirvent JJ
    Med Clin (Barc); 1991 Jun; 97(2):41-4. PubMed ID: 1895780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
    Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.